Moreover, 82.52% (104 cases) of tumours with positive TGF-β signalling showed a high expression of Smad4 in the nucleus and 17.48 % (18 cases) of tumours indicated low expression of Smad4 with negative TGF-β signalling. The gene discussed is SMAD4; the disease is neoplasm.